Here are 10 key notes on orthopedic and spine device companies over the past week.
Nebraska will be the second state in the nation to cover minimally invasive SI joint fusions using the SI-BONE iFuse Implant System.
Implanet generated revenue of €4.094 thousand, representing a 24 percent increase from the same time period in 2015.
Zimmer Biomet pledged up to $100,000 in matching funds to the Orthopaedic Research and Education Foundation.
Zimmer Biomet leads the global hip and knee surgical implants market, which is expected to hit $33 billion by 2022.
Amendia introduced its new spondylolisthesis reduction system for commercial launch.
St. Paul, Minn.-based Spineology expanded its relationship with Musculoskeletal Transplant Foundation, a tissue bank.
Orthobiologics company Cerapedics completed a Series D financing round totaling $11 million.
The Therapeutic Goods Administration of Australia approved AxioMed's Freedom Viscoelastic Disc Replacement technology.
The Centers for Musculoskeletal Disorders in Englewood, N.J., installed Mazor Robotics' Renaissance system.
Regentis Biomaterials recently received FDA approval to begin a phase III clinical study of GelrinC, a treatment for focal cartilage defects in the knee.